Apo-Dustasteride 0.5 mg: Affected lot may contain undersized capsules
Brand(s)
Last updated
Summary
Product
Apo-Dustasteride 0.5 mg
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution
National
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot number |
|---|---|---|---|---|---|
| APOTEX | Apo-Dustasteride 0.5 mg | DIN 02404206 | Capsule | DUTASTERIDE 0.5mg | AW8321A |
Issue
Affected lot may contain undersized capsules.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers, Wholesalers & Pharmacies
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Apotex Inc.
150 Signet Drive
Toronto, ON
M9L 1T9
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type II
Identification number
RA-77719
Get notified
Receive notifications for new and updated recalls and alerts by category.